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Heterogeneity and high plasticity are common features of cells from the mononuclear phagocyte
system: monocytes (MOs), macrophages, and dendritic cells (DCs). Upon activation by microbial
agents, MO can differentiate into MO-derived DCs (MODCs). In previous work, we have shown
that during acute infection with Plasmodium berghei ANKA (PbA), MODCs become, transiently,
the main CD11b+ myeloid population in the spleen (SP) and once recruited to the brain play an
important role in the development of experimental cerebral malaria (ECM). Here, we isolated
4 cell populations: bone marrow (BM) MOs (BM-MOs) and SP-MOs from uninfected mice; BM
inflammatory MOs (BM-iMOs) and SP-MODCs from PbA-infected mice and used a system biol-
ogy approach to a holistic transcriptomic comparison and provide an interactome analysis by inte-
grating differentially expressed miRNAs (DEMs) and their differentially expressed gene targets
(DEGs) data. The Jaccard index (JI) was used for gauging the similarity and diversity among these
cell populations. Whereas BM-MOs, BM-iMOs, and SP-MOs presented high similarity of DEGs,
SP-MODCs distinguished by showing a greater number of DEGs. Moreover, functional analysis
identified an enrichment in canonical pathways, such as DC maturation, neuroinflammation, and
IFNsignaling.Upstreamregulator analysis identified IFN𝛾 as thepotential upstreammolecule that
can explain the observedDEMs–Target DEGs intersections in SP-MODCs. Finally, directed target
analysis and in vivo/ex vivo assays indicate that SP-MODCs differentiate in the SP and IFN𝛾 is a
main driver of this process.
Abbreviations: BM, bonemarrow; CMP, commonmyeloid progenitor; DC, dendritic cell; DEGs, differentially expressed genes; DEMs, differentially expressedmiRNAs; ECM, experimental
cerebral malaria; iMO, inflammatorymonocyte; iRBCs, infected red blood cells; JI, Jaccard Index;MA-ARDS, malaria-associated acute respiratory distress syndrome;MO,monocyte; MODC,
monocyte-derived dendritic cell; PbA, Plasmodium bergheiANKA; SP, spleen.
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1 INTRODUCTION
The mononuclear phagocyte system comprises monocytes (MOs),
macrophages (MAs), and dendritic cells (DCs) with bone marrow
(BM) origin. These cells have high plasticity and share many func-
tional features in the immune defense as well as homeostasis main-
tenance, for example, inflammation-induced migration, cytokine and
chemokine secretion, clearance ofmicroorganisms and apoptotic cells,
antigen processing and presentation.1 During inflammatory response
and/or infection, activatedMOsmigrate fromblood to tissues, produce
inflammatory cytokines, perform antimicrobial functions, and may dif-
ferentiate into MAs or DCs.2,3 These differentiated cells are main
players of innate immune response and host resistance to malaria.4
Infection with Plasmodium vivax or P. falciparum induces significant
increase in circulating MOs, including an inflammatory MO (iMOs)
subset (CD14+CD16+), and changes of their distribution in different
organs, such as spleen (SP), liver, and lungs.5 iMOs recruitment from
BM to blood is mediated by the chemokine CCL2 and its receptor,
CCR2.6 These cells are highly efficient in phagocytizing Plasmodium-
infected erythrocytes and produce ROS,7,8 thus, the expanded iMO
population play a pivotal role in resistance to both human and exper-
imental rodent malaria.9,10
Previous studies from our group have shown that during acute
rodent malaria, another subset of MO, theMO-derived DCs (MODCs)
emerge as a main myeloid population in the SP and non-lymphoid
organs.11,12 We have also shown that the development of experimen-
tal cerebral malaria (ECM) during P. berghei ANKA (PbA) infection is
dependent of splenic MODC infiltration in the brain.11 These cells
promote neuroinflammation by producing critical chemokines (CXCL9
and CXCL10) involved in T cell recruitment to the brain.13 We also
observed that infection of CCR2−/− mice with PbA compromises the
emergence of MODCs in the SP, whereas the migration of MODCs to
the brain and the development of ECM are not affected.11 These find-
ings suggested that splenic MODCs differentiate locally and indepen-
dent from iMOs recruited fromBMs. The omic technologies have been
applied to reveal new factors or markers that allow us to better under-
stand the heterogeneity of theseMO subsets, but these keymolecules
are far from being fully characterized.
MicroRNAs (miRNAs) are a class of noncodingRNAs capable of pro-
moting gene expression regulation by inducing mRNA decay or trans-
lation repression. The miRNA–mRNA (target) pairing is determined
by the called seed region of the miRNA, a sequence of 8 nucleotides
located at the 5´ end of the mature miRNA.14,15 Because of the great
number of possible pair-wise miRNA–-target interactions, computa-
tion models, databases, and tools are essential in the prediction of
biologic function of the miRNAs targets.16 Although miRNA impor-
tance has already been extensively demonstrated, their participation
on overall gene expression control in mechanisms of differentiation
and plasticity of different cell populations during Plasmodium infection
is still poorly explored.
Here, we analyzed the interactome of both differentially expressed
miRNAs (DEMs) and their differentially expressed gene targets (DEGs)
to depict the heterogeneity and differentiation of MOs isolated from
uninfected mice BM (BM-MOs) and SP (SP-MOs), and the newly dif-
ferentiated inflammatory MOs (BM-iMOs) and SP-MODCs from PbA-
infected mice. Strikingly, SP-MODCs present unique DEMs and DEGs
profile with a DC signature. In addition, the combination of functional
in vivo and in vitro assays with an in silico mRNA and miRNA network
predictions we show thatMODCs differentiate in the SP from SP-MO,
not needing to be recruited from the BM and that IFN𝛾 is the main
driver of this process.
2 MATERIALS AND METHODS
2.1 Mice
All animals used in this work were 8–12-weeks old. C57BL/6 were
obtained from either Animal Facility of the UFMG or initially pur-
chased from Jackson Laboratory (Bar Harbor, ME). IL-4−/−, IL-12−/−,
IL-17−/−, and IFN𝛾−−/− mice were obtained from Fiocruz-Minas (Belo
Horizonte, MG, Brazil). The REX3 mouse lineage was kindly provided
by Andrew D. Luster from Massachusetts General Hospital (MGH)17
and the GREAT (IFN𝛾 YFP-reporter) mice by John E. Harris from
UMMS (Worcester,MA, USA). Thesemicewere bred and reared at the
animal facility ofUniversity ofMassachusettsMedical School (UMMS).
All animal procedures were performed in accordance with the guide-
lines of the American Association for Laboratory Animal Science
(AALAS) and approved by the Institutional Animal Care and Use Com-
mittee of the UMMS (IDA-2371-18) as well as the Institutional Ethical
Committee for Animal Experimentation at Fiocruz (CEUA LW15-14).
2.2 Infection
The PbA strain was stored in liquid nitrogen, thawed, and maintained
in C57BL/6 mice by weekly passages for up to 12 weeks. For exper-
imental infection, mice were injected intraperitoneally (i.p.) with 105
infected RBCs. These mice were observed daily and parasitemia was
estimated by counting Giemsa-stained thin blood smears. ECM signs
were evaluated by different parameters that included ruffled fur,
abnormal postural responses, reduced reflexes, reduced grip strength,
coma, and convulsions. Mice that demonstrated complete disability in
all parameters or died between days 7 and 9 postinfection were con-
sidered as having ECM.18
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2.3 SP and BM cell cultures
Spleens and BMs from C57BL/6 mice uninfected and at 6 days
postinfection with PbA were harvested, suspended in RPMI medium
supplemented with 10% of FBS at 10 × 106 cells/ml. Cells were
cultured with medium alone or with LPS (100 ng/ml) for 24 h with
addition of Brefeldin A 6 h prior the end time and processed for
flow cytometry to detect intracellular cytokines. For the main IFN𝛾
source in PbA-infected mice, we used splenocytes and BM cells from
GREAT (IFN𝛾 YFP-reporter)mice. Sampleswere acquired using a LSRII
(BD Biosciences, Franklin Lakes, NJ, USA) cytometer and analyzed
with FlowJo software.
2.4 Flow cytometry
The single cell suspensions of BM or SPs were incubated with
anti-Fc𝛾III/II and fluorochrome-conjugated antibodies against surface
markers in PBS containing 1% FBS for 15 min at room tempera-
ture. CD11b (PE-Cy7, clone: M1/70), F4/80 (PE-Cy5, clone: BM8),
CD11c (Alexa 700, clone: N418), MHCII (APC eFluor-780, clone:
M5/114.15.2), DC-SIGN (APCe-fluor 660, clone:MMD3), and Ly6C (e-
fluor 450, clone: HK1.4) were purchased from eBioscience (San Diego,
CA, USA). CD80 (FITC, clone: 16-10A1) and CD86 (PE, clone: GL1,
BD)were purchased fromBD. CD40 (FITC, clone: 3/23)was purchased
from Biolegend (San Diego, CA, USA) and CCR2 (FITC, clone 475301)
and CCR5 (APC, clone CTC5) were fromR&D (Minneapolis, MN, USA).
In REX3mice, endogenous RFP (CXCL9) and BFP (CXCL10) were read
in PE and Pacific Blue channels, respectively. Sample acquisition was
performed by using a Fortessa or LRSII Cytometers (BD) and analyzed
using FlowJo software. For detection of IFN𝛾-YFP, cells were gated on
CD3+CD4+, CD3+CD8+, or CD3−NK1.1+. The monoclonal antibod-
ies specific for CD3 (FITC, clone 145-2C11), CD4 (APC, clone RM4-5),
CD8 (APC-Cy7, clone 53–6.7), and NK1.1 (BV421, clone PK136) were
purchased from eBioscience and used to gate YFP+ cells. For intracel-
lular detection of cytokines, after surface staining, cells were fixed and
permeabilized using the Cytofix/CytopermTM Kit (BD). Prior to fixa-
tion. Live/Dead Fixable Aqua Cell Stain Kit (Invitrogen, Carlsbad, CA,
USA) was used to exclude dead cells. Cells were stained for 30 min at
4C with TNF-𝛼 (PE, clone MP6-XT22), IL-12p40 (PE, clone C17.8), IL-
10 (FITC, clone JES5-16E3) and NOS2 (PE, clone CXNFT), purchased
from eBioscience. Cells were gated on CD11b+F4/80+ and then on
DC-SIGN+MHCII+ for detection of cytokines onMODCs.19
2.5 Ex vivo differentiation of Ly6Chi MOswith IFN𝜸
Ly6Chi MOsFACSsorted fromtheSPor theBMofuninfectedC57BL/6
mice were cultured with IFN𝛾 (100 ng/ml). After 24 h, dead cells
were excluded using Live/Dead Fixable AquaCell Stain Kit (Invitrogen)
and then stainedwith fluorochrome-conjugated antibodies forCD11b,
F4/80,MHCII, DC-SIGN, and Ly6C as described previously.
2.6 In vivo administration of IFN𝜸
C57BL/6 mice received i.p. injection containing 5 µg of recombinant
carrier-free IFN𝛾 (Biolegend) in 200 µl sterile PBS once each day for
3 days.20 After 16 h of the last injection, mice were euthanized for SP
and BMharvested for detection ofMODCs by flow cytometry.
2.7 Cell sorting
Splenic CD11b+ cells were enriched using magnetically labeled
microbeads (Miltenyi, Bergisch Gladbach, Germany), stained with
Ly6G (PE), CD11b (PE-Cy7), F4/80 (PE-Cy5), CD11c (FITC), MHCII
(APC eFluor 780), and DC-SIGN (APC e-fluor 660), and then purified
by using a cell sorting ARIA (BD). The cells were first gated on SSC-
A/FSC-A followed by FSC-H/FSC-A, to avoid doublets, and then on
Ly6G+ cells to exclude neutrophils (Supplemental Fig. 2). Sorted SP-
MOs and BM-MOs (Ly6G−CD11b+ F4/80+DC-SIGN−MHCII−) from
uninfected mice, as well as BM-iMOs (Ly6G−CD11b+ F4/80+DC-
SIGNloMHCII−) and SP-MODCs (Ly6G−CD11b+F4/80+DC-
SIGNhiMHCIIhi) from infected mice were counted, resuspended
in RNAlater and stored at−20◦C up to RNA extraction.19
2.8 Adoptive cell transfer
Briefly, splenocytes from uninfected CD45.2 donor mice were incu-
bated with a mix of PE-labeled antibodies: CD4 (clone GK1.5), CD8
(clone53–6.7), TCR-b (cloneH57–597), CD19 (clone1D3), Ly6G (clone
1A8), Ly49 (clone YLI-90), and CD11c (clone N418), and MOs were
enriched up to 40–60% using the PE-multisort kit (Miltenyi Biotec) by
negative selection. Enriched MOs (CD11b+F4/80+DC-SIGN−MHCII−
cells) were injected intravenously (i.v.) into 6-week-old, nonirradiated
CD45.1 recipient mice uninfected or 3 days postinfection with PbA.
After 48 h, SP andBMcellswere obtained and analyzed by flow cytom-
etry for detection ofMoDCs fromCD45.2+ or CD45.1+ cells.
2.9 RNA-Seq andmiRNA sample preparation
For RNA-seq and miRNA analysis, biologic replicates (3 samples) of
MOs (SP-MOs) and (BM-MO) from uninfected mice and inflamma-
tory MOs (BM-iMOs), and SP-MODCs from PbA-infected mice were
obtained by cell sorting. RNA-seq libraries were prepared using the
TruSeq Stranded mRNA Kit (Illumina, San Diego, CA, USA) follow-
ing the manufacturer’s instructions. The library was submitted for
sequencing on the Illumina NextSeq 500 (Bauer Core Facility Harvard
University). TheRNAseqdata is available atGeneExpressionOmnibus,
access: GSE126381, platform GPL19057. miRNAs were isolated from
total RNA using the mirVanaTM miRNA Isolation Kit (Thermofisher,
Whaltam, MA, USA), following the manufacturers’ protocol. Expres-
sion profiling of 641 miRNAs was performed using a multiplexed RT
reaction (MegaplexTM RT Primers, Rodent Pool Set v3.0 kit) to pro-
duce cDNA.The cDNAsample andmastermix (TaqManUniversalMas-
ter Mix II, no UNG- Thermofisher) were loaded into preprinted Taq-
Man Low Density Arrays (TLDA) microfluidic cards (Rodent Card A +
B v3, format 384 each). Raw data files (.EDS) were processed using
automatic baseline corrections and manually checked for each assay
if threshold cycle (Ct) value corresponded to midpoint of logarithmic
amplification curve using the software Connect (Thermofisher).
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2.10 RNA-Seq andmiRNA statistical and
bioinformatics analysis
For RNA-seq, reads previously trimmed with Trimmomatic 21 were
mapped to the Genome Reference Consortium Mouse Build 38 patch
release 5 (GRCm38.p5) using STAR aligner 22 and the Fragments Per
Kilobase of transcript per Million mapped reads (FPKM) values were
calculated with CUFFLINKS 23 to the following contrasts: BM-MOs
x BM-iMOs, SP-MOs x SP-MODCs, BM-MOs x SP-MOs, BM-MOs
x SP-MODCs and BM-iMOs x SP-MODCs. MicroRNA statistical
analysis was carried using the Linear Model for microarray data
(Limma) with comparisons p-values submitted to false discovery rate
(FDR) adjustment according to the Benjamini–Hochberg method
(https://www.jstor.org/stable/2346101).24 The miRNAs and genes
were considered differentially expressed if adjusted P ≤ 0.05 and
absolute fold change FC ≥ 1.5) (Supplemental Table 1). The compara-
tive threshold cycle method was used to calculate the relative miRNA
expression (ΔCt) after global normalization. The samples hierarchical
clustering was performed using the squared Euclidean distance of
measure method and z-score normalization for the top 2000 most
variable genes (FPKM values) and 351 miRNAs (ΔCt values). The
principal component analysis (PCA) of gene and miRNA expression
was performed for all samples and the same set of miRNAs and genes
used in the hierarchical clustering by using a median centering of the
data set. The x-axis corresponds to principal component 1 (PC1) and
y-axis to the principal component 2 (PC2) and the percentages of
variance in both. Both hierarchical clustering and PCAwere built using
ClustVis web tool.25
2.11 DEGs-DEMs integration, functional,
and network analysis
MiRNA target prediction, canonical pathways, network and upstream
regulator analysis were performed with ingenuity pathway analysis
(IPA; Qiagen, Hilden, Germany). ThemiRNAs and gene expression pro-
files were integrated to identify putative targets within the differen-
tially expressed genes of the differentially expressedmiRNAsusing the
IPA target filter tool which relies on 3 popular algorithms (TargetScan,
TarBase, and miRecords) enabling prioritization of experimentally val-
idated and high predicted mRNA targets based on the content of date
2019–12.
IPA was also used to identify significantly enriched canonical path-
ways within the list of DEMs and their target DEGs and to build
DEMs-DEGs (considering fold change inverse pairing) networks. The
significance of the association between each list and the pathway was
measured by Fisher’s exact test. As a result, a P value was obtained,
determining the probability that the association between the genes
in our data set and the networks generated can be explained by
chance alone.
2.12 Venn diagrams and Jaccard similarity index
To accomplish testing following 2 hypothesis studied here, we per-
formed pairwise comparisons between the lists of DEGs from all cell
types involved in each possible differentiation route (P value ≤ 0.05
and FC ≥ 1.5): Hypothesis 1: BM-MOs x BM-iMOs, BM-MO x SP-
MODC, BM-iMO x SP-MODC; and Hypothesis 2: BM-MOs x SP-
MODCs, BM-MOs x SP-MO, and SP-MOs x SP-MODCs. Using the
overlap DEGs numbers between the Venn diagrams, we measured the
similarity between sets using the Jaccard index.
2.13 Flow cytometry data statistical analysis
All flow cytometry data represented with bar graphs was analyzed
usingGraphpad Prism8.0 Software. The difference between 3 ormore
groups was verified using 2-way ANOVA test via Bonferroni’s test for
multiple comparisons. The differences between 2 groupswere verified
using the t-test for parametric data. A P ≤ 0.05 value was considered
statistically significant.
3 RESULTS
3.1 MOpopulations dynamics and phenotypic
heterogeneity in the SP and BMof PbA-infectedmice
Here, we characterizeMO subsets harvested from BM and SP of unin-
fected and C57BL/6 mice at 6 days postinfection with PbA. During
PbA infection, splenicMODCs, that represents over 60% of totalMOs,
are CD11b+F4/80+DC-SIGNhiMHCIIhi and express different levels of
Ly6C, whereas iMOs (approximately 25% of total MOs) are Ly6Chi
and CD11b+F4/80+DC-SIGNintMHCII− cells. We have also identified
in the BM of PbA-infected mice newly differentiated inflammatory
MOs (iMOs) and a MODC-like population that share some markers
with MODCs, such as DC-SIGN and MHCII (Figs. 1A and B). Thus, to
determine the equivalence between BM MODC-like and SP-MODCs,
we evaluated the expression of previously described markers.4 SP-
MODCs express CD11c and other activation markers, such as, CD80
and CD40; the chemokines CXCL9 or CXCL10 and most importantly
the receptor CCR5 which is essential for migration of MODCs to the
brain anddevelopmentof ECM.11 In contrast, BMMODC-like cells lack
in the expression of these markers (Fig. 1C). In addition, LPS-activated
MODCs, but not the MODC-like cells, express high levels of TNF𝛼, IL-
10, and iNOS 26 and Plasmodium12 infection. Hence, BM MODC-like
cells are not matureMODCs (Supplemental Figs. 1A and B).
Inflammation or infection can induce iMOs differentiation into
MODCs 6,27 and egress of these cells from BM is CCR2-dependent.28
However, a previous study fromour group has shown that during ECM,
the emergence of splenic MODCs is only partially compromised in
PbA-infected CCR2−/− mice.11 Here, we observed that emergence of
MODCs in the SP parallels the parasitemia, whereas MO and iMOs
decrease overtime. On the other hand, in the BM there is a signifi-
cant enrichment of iMOs with infection, which on day 7 postinfection
represents the predominant population among total CD11b+F4/80+
MOs (∼50%) (Figs. 1D and E and Supplemental Fig. 1C). In addition,
BM iMOs express intermediary levels of DC-SIGN, suggesting that
this population could be an intermediate differentiation state and con-
tribute for the PbA-induced splenicMODCs.
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F IGURE 1 Monocyte andMODC populations in the spleen and bone marrow of PbA-infected mice. Spleens and BMs were harvested 6 days
after PbA infection. (A) Splenocytes or BM cells were first gated for CD11b+F4/80+ cells and then for DC-SIGN andMHCII expression. (B) Expres-
sion of Ly6C and DC-SIGN was evaluated in CD11b+F4/80+DC-SIGN+MHCII+ cells. The data shown are representative of 3 independent exper-
iments. (C) Splenic and BM CD11b+F4/80+DC-SIGN+MHCII+ cells were evaluated for the expression of DC/ MODC markers and chemokines,
such as, CD11c, CD40, CD80, CXCL9, CXCL10, andCCR5. Dotted lines show cells fromuninfectedmice and full lines from infectedmice. Numbers
indicate MFI for each marker on infected samples. (D) Emergency of DC-SIGN+MHCII+ cells in the spleen and BM follows the increase in of para-
sitemia in PbA-infected mice. Line graphs shows the frequency of eachMO population within CD11b+F4/80+ cells. (E) Parasitemia was estimated
by counting Giemsa-stained thin blood smears and is expressed as percentage of infected RBCs. Data shown are representative of 2 independent
experiments. Results are expressed as average± S.E.M. **P≤ 0.001
3.2 Unsupervised and interactome analyses of
differentially expressed genes andmiRNAs inMO
subsets during PbA infection
Inorder todetermine the similarities andheterogeneitiesof SPandBM
MO populations, we purified 4 cell populations (Supplemental Fig. 2):
SP-MO and BM-MO cells (Ly6G−CD11b+F4/80+DC-SIGN−MHCII−)
from uninfected mice and BM-iMOs (Ly6G−CD11b+F4/80+DC-
SIGNintMHCII−) and SP-MODCs (Ly6G−CD11b+ F4/80+ DC-
SIGNhiMHCIIhi) from PbA-infected mice. In Fig. 2A, we summarized
the data processing and analysis of gene and miRNA expression
profiles as a workflow. Briefly, statistical analysis and identification of
DEGs and DEMs were performed and both transcriptome data were
submitted to unsupervised analyses based on PCA, heatmap repre-
sentation of hierarchical clustering and Jaccard index (JI) analysis,
in order to observe grouping and/or segregation of the 4 MO popu-
lations. The list of DEGs and DEMs, were also used for integration,
network, miRNA target, upstream regulator, and functional analyses.
As shown in Fig. 2B, unsupervised analysis based on the expression
of 2000 genes and 351 miRNAs with the higher expression variance
showed segregation of the 4 groups and intergroup clustering both
in PCA and hierarchical clustering indicating that gene and miRNA
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F IGURE 2 Profiling of differentially expressed genes and miRNAs in MO populations during PbA infection. (A) Workflow of data process-
ing and analysis of gene and miRNA expression profiles BM and SP cells from C57BL/6 mice were used for FACS isolation of the specific cell
populations: SP-MO and BM-MO cells (Ly6G−CD11b+F4/80+DC-SIGN−MHCII−) from uninfected mice; BM-iMO (Ly6G−CD11b+F4/80+DC-
SIGNintMHCII−) and SP-MODC (Ly6G−CD11b+F4/80+DC-SIGNhiMHCIIhi) from mice 6 days post-infection with PbA. (B) Principal component
analysis (PCA) based on the top 2000 differentially expressed genes (DEGs) and 500 differentially expressed miRNA (DEMs) was performed, by
using a median centering of the data set (the percentage of the variance is indicated between brackets). Heatmap and hierarchical clustering was
performed on all the samples using squared Euclidean distance measure and Ward’s method for linkage analysis and z-score normalization. Each
row represents 1mRNA (left panel) andmiRNA (right panel) significantly regulated and each column represents 1 sample. Specific cell populations
are designed by the following colors: BM-MO: blue, BM-iMO:magenta, SP-MO: green, and SP-MODC: red. The color-coded scale (blue: expression
levels lower than the mean and red: expression level over the mean) illustrates the mRNA and miRNA fold change (log2ΔCt) after global normal-
ization is indicated at the bottom of the figure. (C) Schematic representation of the mathematical test of 2 hypotheses on preferential MODC
differentiation route. Hypothesis 1: assumes that BM-MOs differentiates on BM-iMOs during infection and then migrate to the spleen where
they complete maturation to SP-MODCs. Hypothesis 2: assumes that resident SP-MO along with BM-MO that migrate to the spleen during infec-
tion with an unchanged phenotype will differentiate into SP-MODC. The Venn Diagram indicate all the possible virtual comparisons between the
cells on the tested hypothesis. In these diagrams, we compare DEGs from each differential analysis. Yellow dots indicate the intersection where
is expected the biggest change on gene expression, that is in agreement with the organ where the differentiation took place. Red and orange dots
indicate those intersections where is expected few genes in commonmainly because they make reference to the migration process and we expect
that duringmigration the cells suffer aminor change on
expression profileswere specific to each cell population. Both PCAand
hierarchical clustering showed that BM-MOs (blue dots) and SP-MOs
(green dots) samples grouped together, indicating similarities in tran-
scriptome profiling. SP-MODCs (red dots) and BM-iMOs (magenta
dots) clustered apart, indicating that these populations are unique and
present individual DEGs andDEMs profile.
Next, using the list of DEGs, we have tested 2 hypotheses regard-
ing the possible routes of MODC differentiation: hypothesis 1, the
MODC differentiate from BM-MOs into BM-iMOs and then migrate
to the SP where they complete their differentiation; or hypothesis
2, BM-MOs migrate to SP where they compose the pool of SP-MOs,
whichdifferentiate intoMODCuponPbAchallenge (Fig. 2C). If the first
hypothesis is true, we expected that the contrast BM-MO versus BM-
iMOS would show a greater number of DEGs than BM-iMOs versus
SP-MODCs. And, if the second hypothesis is correct, BM-MOs/BM-
iMOS versus SP-MOs would show less DEGs, which would be more
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TABLE 1 Jaccard index to test what of the 2 hypotheses aboutMODC differentiation route during PbA infection is more probable to happen
Pairwise contrasts JI Expected Observed
Hypothesis 1
[BM-MOxBM-iMO] × [BM-MOxSP-MODC] 0.16 Highest proportion Lowest proportion
[BM-MOxBM-iMO] × [BM-iMOxSP-MODC] 0.18 Low proportion Low proportion
[BM-MOxSP-MODC] × [BM-iMOxSP-MODC] 0.48 Low proportion Highest proportion
Hypothesis 2
[BM-MOxSP-MODC] × [SP-MOxSP-MODC] 0.53 Highest proportion Highest proportion
[BM-MOxSP-MO] × [BM-MOxSP-MODC] 0.15 Low proportion Low proportion
[BM-MOxSP-MO] × [SP-MOxSP-MODC] 0.10 Lowest proportion Lowest proportion
Jaccard Index (JI) express the similarity and diversity of sample sets, which is calculated as intersection DEGs/union DEGs. JI = 1 is the highest similarity
between contrasts. Expected highest and lowest proportion means closer of 1 and 0, respectively. A concordance between what is observed in relation to
what is expected indicates which hypothesis is true.
pronouncedwhen comparingBM-MOs/BM-iMOS/SP-MOs versus SP-
MODCs. For this analysis, we used the JI as indicator of similarity
between the sets of genes of different MO populations. This parame-
ter is expressed in percentage that is given by the Venn diagrams inter-
section, shared Venn diagrams Union and the extent of shared genes
between the comparisons (JI values close to number 1 or 100% corre-
spond to similarities between comparisons). The yellow and red dots
in the diagram of Fig. 2C illustrates the expected quantity of shared
genes between theDEGs: higher and lower in proportion, respectively.
Considering the expected proportions of shared genes between the
tested DEGs, we observed JI for the highest expected proportion of
0.53 (53%) and the lowest expected proportion of 0.10 (10%) when
testinghypothesis 2 (Table1), suggesting that this is themost likely cor-
rect 1 and differentiation of MOs into MODCs occurs predominantly
in the SP.
3.3 Identification of DEMS, DEGs, and
DEMs-Target/DEGs pairs in each cell population
AnalysiswithBenjamini–Hochberg false discovery rate (FDR) adjusted
P≤0.05andFCcutoff of 1.5 revealed thehighest numberof bothDEGs
and DEMs in the contrast SP-MODC versus SP-MO. The total num-
ber of DEGs was 2,704 DEGs (1,648 up-regulated and 1,056 down-
regulated) and 70 DEMs (40 up-regulated and 30 down-regulated).
The comparison between BM-iMOs versus BM-MOs showed a total
of 1,686 DEGs (930 up-regulated and 756 down-regulated), and
36 DEMs (20 up-regulated and 16 down-regulated). Supplemental
Table 1 lists all DEGs and DEMs described above. Next, we used a
miRNA target prediction tool from ingenuity pathway analysis soft-
ware (IPA) to screen putative targets of DEMs within the list of DEGs
for each cell population. This analysis pairs the DEMs with their puta-
tive target DEGs considering an inverse expressing pairing relation-
ship betweenmiRNA and its target gene (if themiRNA is up-regulated,
its gene target must be down-regulated and vice versa). We only con-
sidered those target DEGs that have been highly predicted as targets
(from TargetScan database) and/or experimentally validated as targets
(frommiRecords, TarBase, and direct acquisition from the literature by
Ingenuity knowledge Base-IKB). From the list of 70 DEMs identified
on SP-MODCs we found targeting information of 42 of them.We thus
obtained a list of 496 target DEGs of the 42 DEMs in SP-MODCs. For
the BM-iMO cells, from the list of 36 DEMs after filtering we obtained
a list of 18 DEMs targeting a total number of 122DEGs (Supplemental
Table 2). The top 2miRNAswith the highest number of targetsDEGs in
each cell groupwere:mmu-miR-16-5p andmmu-miR-29b for BM-iMO
targeting 32 and 21DEGs, respectively. For theMODCsmmu-miR-16-
5pandmmu-miR-491wereamong themost representedmiRNAs,with
64 and 51 target DEGs, respectively.
3.4 Target DEGs set enrichment analysis reveals
potential pathways regulated bymiRNAs during
MODC differentiation in PbA-infectedmice
In Figs. 3A–C, Venn diagrams show the number of common and unique
DEGs, DEMs, and target DEGs between BM-iMOs and MODCs.
Supplemental Fig. 3 depict these molecules lists. To explore the gene
pathways that were enriched in BM-iMOs and SP-MODCs during PbA
infection, we carried a functional and canonical pathway analysis using
the IPA software. A heatmap representing the enriched pathways
shows that MODCs and iMOs exhibit multiple pathways in common;
however, some pathways, such as, inflammatory responses and hema-
tologic system development and function were highly activated in
MODCs (bigger boxes with high z-score seen in orange) and not in
iMOs (Fig. 3D). Canonical pathway analysis of the DEGs was per-
formed for each cell group. In Fig. 3E, we show 12 canonical pathways
among the most enriched pathways found for each cell type contrast
displaying their predicted activation/inhibition status based on their
z-score (activated processes are orange, whereas inhibited processes
are blue). The stacked bar charts show the percentage of target DEMs
down-regulated (in green) and up-regulated (red) in each 1 of the
enriched pathways for each cell population (Fig. 3F). For bothMO sub-
sets, we observed overrepresentation of canonical pathways related
to immune processes. For the SP-MODCs, IFN signaling, neuroin-
flammation, TREM1, and NF-kB signaling and, most importantly, DC
maturation pathway were predicted to be upregulated (orange),
whereas PPAR and chemokine signaling were predicted to be down-
regulated (blue). Furthermore, in BM-iMOs, IFN signaling, IRF and
PPAR𝛼 pathways were predicted to be activated, whereas innate
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F IGURE 3 Differentially expressed genes and miRNAs and functional pathways enriched during MODC differentiation. (A) Venn diagram
showing the number of differentially expressed genes and (B) miRNAs in SP-MODCs and BM-iMOs and intersected genes. (C) Venn diagram with
the number of targets DEGs (high predicted and experimentally validated targets) in iMOs and MODCs as well as those that are shared between
these 2 cell populations. (D) Enriched ingenuity pathway analysis (IPA) categories ofDEGs inBM-iMOs and SP-MODCs.Diseases andbiologic func-
tion pathways colored by z-score that measure the activation state of these processes (blue: inhibited and orange: activated); sized by the number
of genes: the bigger the box themore genes of the provided list it contains. On the scale bluemeans lower activation levels and orange higher acti-
vation levels. (E) Ingenuity pathway analysis shown for differentially expressed genes (DEGs) and (F) microRNAs (DEMs). Pathway analysis for the
comparison SP-MODC versus SP-MOor BM-iMOversus BM-MO. For DEGs, we shown canonical pathwaysmost significantly enriched colored by
their activation (z-score) the activated pathways (high z-score) are in orange and inhibited (low z-score) are in blue. To DEMs target analysis, the
numerical value in the top of each pathway bar represents the total number of genes in that canonical pathway. The stacked bar charts display the
percentage of target DEGs that are positively (red), negatively (green), no change (black), and no overlap with IPA database (gray). In all analysis,
the Benjamini–Hochberg false discovery rate (FDR) was usedwith adjusted P≤ 0.05 and a fold change (FC) cutoff≥ 1.5
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F IGURE 4 Upstream regulator and DEM/DEG network of MODC differentiation during PbA infection. (A) Upstream regulator analysis of
the DEM targets in BM-iMOs and SP-MODCs. Orange or blue color represent activated or inhibited, respectively, according to z-score prediction
statistical calculation of the upstream regulator activation state in both cell populations. (B) DEM-DEGnetworks for SP-MODC transcriptome and
microRNA data using IPA software. Built network contain the top 2 miRNAs found to potentially regulate the highest number of targets DEGs
(mmu-miR-16-5p and mmu-miR-491) in the context of DC maturation and neuroinflammation, both predicted to be activated (orange). Relation-
ship between molecules is represented as a line (direct or indirect relationship). The molecules colors in graduation of red and green represent if
their fold change is up or down regulated, respectively
and acquired immune response, TREM1 and NF-kB signaling were
down-regulated.
3.5 Upstream regulator analysis andDEM/DEG
networks revealed IFN𝜸 as a keymolecule during PbA
infection
The upstream regulator analysis tool from IPA was used to identify
potential upstream regulators by analyzing linkage to DEM targets
throughcoordinatedexpression. Theanalysis indicated that IFN𝛾 is the
top upstream expression regulator, followed by other cytokines like
IL-4, TNF𝛼, CSF2, IL-6, IL-1𝛽 , IL-3, IL-2, IL-5, and CD40LG predicted to
be activated (orange) or inhibited (blue), based on their z-score value
(Fig. 4A). In order to investigate the possible role ofmiRNAs in regulat-
ing key DEGs inMODC activation and differentiation, we built a DEM-
DEG network for theMODC population, with the top 2miRNAs found
to potentially regulate the highest number of targetsDEGs (mmu-miR-
16-5p and mmu-miR-491). The built network and prediction analysis
revealed the potential role/connection of these 2 miRNAs and their
target DEGs in regulating key biologic and pathophysiologic process
in the malaria context: DC maturation and neuroinflammation, both
predicted to be activated (orange) (Fig. 4B). The network shows the
potential targets for mmu-miR-16-5p: Protein kinase Akt-3 (AKT3),
amyloid precursor protein (APP), CD40 receptor (CD40), C-X-C motif
1192 ASSIS ET AL.
F IGURE 5 Role of IFN𝜸 on the differentiation of MODCs during PbA infection. Spleens and BMs were harvested 6 days after PbA infection.
(A and B) Splenocytes or BM cells were obtained from C57BL/6, IL-4−/−, IL-12−/−, IL-17−/−, and IFN𝛾−/− mice. Total cells were first gated for
CD11b+F4/80+ cells and then for DC-SIGN+MHCII+ cells. Bar graphs correspond to frequency of DC-SIGN+MHCII+ cells within total mono-
cytes CD11b+F4/80+. The data shown are representative of 2 independent experiments. Results are expressed as average ± S.E.M. Two-way
ANOVA analysis of variance comparing splenic versus BM cells in infected C57BL/6 mice. ***P < 0.0001; **P < 0.001. (C) Splenocytes and BM
cells were collected from naïve C57BL/6mice for sorting of monocytes CD11b+Ly6C+. Isolated cells were cultured with IFN𝛾 (100 ng/ml) for 24 h
and then analyzed for MODC differentiation by flow cytometry. Contour plot shows live monocytes (CD11b+ Ly6C+F4/80+) being evaluated for
the expression of DC-SIGN andMHCII (MODCphenotype). (D) Bar graphs correspond to frequency of DC-SIGN+MHCII+ cells within total mono-
cytes CD11b+F4/80+ in cultures treated with IFN𝛾 or not (RPMI). (E) C57BL/6 mice were administered recombinant IFN𝛾 or PBS once per day
for 3 days. Spleen and BM were collected 18 h after the final injection. Contour plot show the frequency of DC-SIGN+MHCII+ cells within total
monocytes CD11b+F4/80+and histogram show the expression of CD11c on this cell. Statistical analysis was performed by 2-tailed nonparametric
unpaired t-test at 95%CI. The data shown are representative of 3 independent experiments. ***P< 0.0001
chemokine ligand 10 (CXCL10), major histocompatibility complex,
class II (HLA-DQA1), IFN gamma receptor 2 (IFNGR2), IL-1 receptor-
associated kinase 2 (IRAK2), mitogen-activated protein kinase 9
(MAPK9), prostaglandin endoperoxide synthase 2 (PTGS2), and TLR1,
all connected to neuroinflammation pathway. For the mmu-miR-
491-5p the targets DEGs present in the network were: TLR9, innate
immune signal transduction adaptor (MYD88), intercellular adhesion
molecule 1 (ICAM1), major histocompatibility complex (HLA-DQA1),
class II, DQ beta 1 and DM alpha (HLA-DQB1, HLA-DMA), and fascin
actin-bundling protein 1 (FSCN1), connected toDCmaturation. Impor-
tantly, IFN𝛾 was shown to be a node interconnecting a great number
of DEMs and DEGs, suggesting that this cytokine is a central molecule
ASSIS ET AL. 1193
F IGURE 6 Differentiation of splenic MO into MODCs during PbA infection. Enriched splenic F4/80+CD11b+DC-SIGN−MHCII− cells from
uninfected CD45.2+ donor mice were adoptively transferred i.v. into CD45.1+ uninfected or PbA-infected mice. Dot plot of enriched monocytes
show that∼99%of the cellswereundifferentiatedmonocytesDC-SIGN−MHCII− (MO). After 48h, spleens andBMof recipientmicewereobtained
and frequency of CD45.2+ donor-derivedMODCswere comparedwith recipient-derivedCD45.1+ MODCs. Bar graphs show frequency ofMODC
in F4/80+CD11b+ populations fromCD45.2+ or CD45.1+ cells of 2 pooled experiments that yielded similar results
in the process ofMODCdifferentiation and neuroinflammation during
PbA infection.
3.6 IFN𝜸 is a key factor for the differentiation of
MODCs during PbA infection
To test the hypothesis that IFN𝛾 is the key factor onMODC differenti-
ation, we infected knockout mice for either IL-4, IL-12, IL-17 and IFN𝛾
genes and at 6 days post-infection, SP and BMwere used to determine
the frequency of MODCs. Notably, only IFN𝛾−/− mice fail to differ-
entiate splenic MODCs (Figs. 5A and B). IFN𝛾 deficiency leaded to an
accumulation of splenic iMOs that did not differentiated into MODCs
(Supplemental Fig. 3A). We also show that CD4+ and CD8+ T cells are
the main source of IFN𝛾 in the SP.11,18,29 The IFN𝛾 producing CD4+
andCD8+ T cellswere also found in a lownumber in theBMof infected
mice. NK cells were present in both compartments but represented a
smaller fraction of the IFN𝛾 producing cells (Supplemental Figs. 3B and
C). During PbA infection CD4+ and CD8+ T cells represents approxi-
mately 18 and 8% of total splenic cells, respectively; and comprise less
than 4% of total BM cells (data not shown), indicating that the pro-
duction of IFN𝛾 in the SP is far more abundant. Next, we tested if IFN𝛾
would be sufficient to induceMOs to differentiate intoMODCs in vitro
and in vivo. Culturing SP-MOs or BM-MOs (CD11b+Ly6C+) isolated
from naïve mice in the presence of rIFN𝛾 induced the expression of
DC-SIGN and MHCII indicating a differentiation towards MODCs
(Fig. 5C and D). In addition, naïve WT (Fig. 5E—top panel) or IFN𝛾−/−
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(Fig. 5E—bottompanel) mice treatedwith rIFN𝛾 presented an increase
of CD11b+F4/80+DC-SIGNhiMHCIIhi cells both in the SP and BM. In
summary, we observed that IFN𝛾 is a central DEM–DEG network hub,
which indicate the importance of this molecule in the biologic process
ofMODC differentiation during PbA infection.
3.7 Differentiation of splenicMO intoMODCs
during PbA infection
According to our hypothesis, MODCs differentiate from resident SP-
MOs. By using an adoptive cell transfer experiments, we evaluate the
ability of SP-MOs to differentiate into MODCs in vivo during PbA
infection (Figs. 6A–C). MOs (F4/80+CD11b+DC-SIGN−MHCII−) were
enriched from SPs of uninfected CD45.2 C57BL/6 mice and 2 × 106
cells were transferred to either uninfected or PbA-infected CD45.1
congenic mouse. Two days later, the frequencies of donor CD45.2+
MODCs were evaluated in the SP and BM. In infected mice, like
host cells (CD45.1+), most splenic CD45.2+ MOs differentiated into
splenic MODCs (F4/80+CD11b+DC-SIGNhiMHCIIhi). Likewise, these
MOsmigrate to the BM,where they also expressDC-SIGN andMHCII.
Thus, we favor the hypothesis that SP-MOs aremain precursor cells or,
at least, enough to generate the pathogenic MODCs that migrate and
promote ECM in the PbAmodel.
4 DISCUSSION
The parasite–host interaction is complex and should be tightly regu-
lated from the immunologic point of view: parasites evade the immune
response to avoid elimination from the host; whereas antiparasite
immune responses try to limit the invasion and parasite prolifera-
tion without eliciting significant collateral damage. Among the innate
immune cells, MOs and DCs play an important role in host resistance
to Plasmodium infection and pathogenesis of malaria.30-32 The acti-
vation of these innate immune cells and consequent systemic inflam-
mation lead to the initial signs and symptoms of malaria. Activation
of MOs, cytokinemia, cytoadherence of iRBCs, and anemia associated
with the severe and lethal forms of the disease, including cerebral
malaria. While the extensive heterogeneity of these cells is evident,
the functional significance of their differentiation during infection
remains elusive.
The aim of this study was to integrate both miRNome and tran-
scriptome data from MO subpopulations to broaden our understand-
ing and gain insight in how miRNAs translation during differentiation
of the plastic MO populations during PbA infection. Splenic MODCs
differentiated during PbA infection are characterized by the pheno-
typeCD11b+F4/80+DC-SIGNhiMHCIIhi, expression of different levels
of Ly6C and DC maturation and activation markers, such as, CD11c,
CD80, CD40. In addition, splenic MODCs express the receptor CCR5,
essential for migration to the CNS 11 and the chemokines CXCL9 and
10, involved in the recruitment of activated T lymphocytes express-
ing CXCR3 and development of ECM.13 On the other hand, iMOs
areCD11b+F4/80+DC-SIGNintMHCII−CD80− and display low phago-
cytic activity compared to MODCs.11,32 Here, we have also identified
another cell population MODC-like, which share some markers with
MODCs, such as DC-SIGN and MHCII, but lack markers of mature
DCs, i.e. CD40, CD86, CCR5, CXCL9, or CXCL10. In addition, splenic
MODCs, but not BMMODC-like, produce high levels of cytokines and
express iNOS in response to LPS, indicating that BMMODC-like cells
are not mature or functionalMODCs.
Moreover, PbA infection induces expansion of newly differentiated
iMOs in the BM. Importantly, the egress from BM and the emer-
gence of iMOs in nonlymphoid as well as peripheral lymphoid organs
was previously shown to be CCR2 dependent.28 However, the gen-
eration of splenic MODCs is only partially compromised, whereas
the migration of MODCs to the CNS and the development of ECM
are not affected in PbA-infected CCR2−/− mice.11 In addition, the
high frequency of iMOs (CD11b+F4/80+CD11c−DC-SIGNintMHCII−)
and not MODCs (CD11b+F4/80+CD11c+ DC-SIGNhiMHCIIhi) in
the BM from PbA-infected mice further suggest that MODCs are
differentiating elsewhere.
MicroRNAs have been found to be fine tuners of different bio-
logic processes by post-transcriptionally controlling gene expression.
They can indirectly control the immune system homeostasis by tar-
geting cytokines, enzymes, transcription factors, and other regulatory
molecules and their dysregulated expression is associated with differ-
ent pathologies, including infectious diseases and immune disorders.
Here, we identified DEMs and DEGs profiles to determine the
potential site(s), regulatory molecules and processes related to
SP-MODCs differentiation during PbA infection. The transcriptome
profiling showed a great number of DEMs and DEGs. The unsuper-
vised analyses (PCA, hierarchical clustering and Jaccard index) of
both transcriptomes’ profiles were able to segregate the differentMO
subsets. The Jaccard index (JI) also called the Jaccard similarity coef-
ficient is a measure of similarity used to comparemembers from 2 sets
showing which ones are shared and which are distinct. The JI has been
previously used as a measure of similarity between 2 sets of data in a
great number of studies, for example, tumorigenesis,33,34 systematic
phenotyping of human cells in different diseases 35 and re-annotation
of Drosophila genomes.36 The analysis supported the hypothesis that
the SP-MOs are likely to be the main progenitors for SP-MODCs and
differentiation of MOs into MODCs occurs predominantly in the SP.
This hypothesis is corroborated by earlier studies showing thatMODC
differentiation may occur in the site of infection,26,37 and is further
supported by our data showing that MODCs still emerge in the SP
of PbA-infected CCR2−/− mice that have an impaired egress of iMOs
from the BM.11 We also used the adoptive cell transfer experiments,
and the results showed that SP-MOs differentiate into SP-MODCs,
validating this hypotheses.
Canonical pathway and integration of DEGs and DEMs analy-
sis showed an enrichment in pathways related to immune response.
Importantly, the DC maturation signaling pathway was exclusively
enrichedonSP-MODCsandother canonical pathways sharedbetween
the 2 cell groups were: IFN, TLR, activation of IRF, PPAR activation,
NF-𝜅b, andneuroinflammation signalingpathways.Computational and
integration analysis revealed the number of DEGs, DEMs, and Target
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DEGs in common and unique for each cell population. We observed
that a great number of DEGs are potential DEMs targets in both cell
populations with a higher number in SP-MODCs.
Our analysis revealed 2 top miRNAs (both down-regulated in SP-
MODC), mmu-miR-16-5p and mmu-miR-491, as potentially regula-
tors of the majority of target DEGs on SP-MODCs. The built network
and prediction analysis showed that mmu-miR-16-5p have 10 puta-
tive target DEGs (AKT3, APP, CD40, CXCL10, HLA-DQA1, IFNGR2,
IRAK2,MAPK9, PTGS2, andTLR1) all nodemolecules are up-regulated
and indirectly connected to activation of neuroinflammation signal-
ing. The DEM mmu-miR-491-5p showed 6 target DEGs molecules
(TLR9,MYD88, ICAM1, HLA-DQB1, HLA-DMA, and FSCN1), and indi-
rectly connected to DC maturation. Importantly, the network also
showed IFN𝛾 as a node interconnecting a great number of DEMs
and DEGs in the network. An upstream regulator analysis based
on the DEGs profiles also indicated that IFN𝛾 is the top 1 poten-
tial upstream key cytokine modulating the observed transcriptional
changes. These both findings indicate that this cytokine is a central
molecule in the process of MODC differentiation and neuroinflam-
mation during PbA infection. The mouse miRNA-16-5p (mmu-miR-
16-5p) (ID: MIMAT0000527) is down-regulated in SP-MODCs. This
miRNA is part of the mir-15 gene family, which include 6 highly con-
served miRNAs (miR15a/15b/16/195/497), which are clustered on
3 separate chromosomes and their mature miRNAs have the same
seed sequence.
The precursors of mmu-miR-16-5p are mmu-mir-16-1 and mmu-
mir-16-2 located in chromosome 14 and 3, respectively.38 It was first
described by Calin et al.39 as deleted or down-regulated in chronic
lymphocytic leukemia. The entire family appears to function as cell
proliferation in lymphoid and nonlymphoid cells. It was also found
down-regulated in plasma of P. vivax infected patients and may be
potential biomarkers for malaria infection.40 Our network analysis
showed that miR-16-5p and miR-491-5p have potential targets
related to neuroinflammation and DCmaturation: MiRNA-491-5p has
2 targets, TLR9 andMYD88, crucial molecules for the development of
protective immunity to malaria.41 Among the miR-16-5p target genes
are CD40, CXCL10, IFNGR2, and PTGS2, all previously described as
implicated in the pathogenesis of ECM.42,43
Oneof the limitations of the analysis performedhere is that is based
in a broad systematic analysis providing an overview ofmiRNA–mRNA
networks, and correlation is not proof of causality. So, we decided
to experimentally validated IFN𝛾 regulatory function in MODC dif-
ferentiation by treating MOs with IFN𝛾 either in vitro or in vivo and
we observed that the treatment alone was enough to induce MODCs
differentiation. Similar effect was observed in the SP and BM, indi-
cating BM-MOs can complete their differentiation to MODCs, if pro-
vided sufficient levels of IFN𝛾 . During ECM andMA-ARDS, CD4+, and
CD8+ T cells are the main source of IFN𝛾 in the SP and lungs.11,12,46
Since the T lymphocytes are in high frequency in the SP, but not in
the BM, we believe that in IFN𝛾-treated mice, but not in PbA-infected
mice, this cytokine reaches high enough levels to induce BM-MO dif-
ferentiation into BM-MODC.20,47 Moreover, a recent study demon-
strates that IFNGR2 expression on brain epithelial cells are also impor-
tant for the development of ECM.45 These data are intriguing, tak-
ing that migration of MO-DCs expressing high levels of IFNGR2 is
required for the development of ECM and impairment of MODC
differentiation is observed in IFN𝛾R1−/− mice that are resistant to
ECM.11,44 These findings suggest that IFN𝛾R1 may be more relevant
for MOs differentiation and migration of MODCs, to the CNS during
PbA infection.
In conclusion, we have shown that IFN𝛾 is the key factor onMODC
differentiation. The built network implies IFN𝛾 as a central molecule
(node molecule) interconnecting a great number of DEMs and DEGs
being an upstream regulator. We also provide experimental evidences
that IFN𝛾 is a main factor orchestrating the differentiation of MODCs
during PbA infection. Our data also support that MODCs differen-
tiate primarily from SP-MOs, contrasting with a more conventional
route of differentiation from BM-iMOs and recruited to peripheral
lymphoid organs and non-lymphoid tissue. Finally, by using a com-
bination of functional in vivo and in vitro assays with an in silico
mRNA and miRNA network predictions, our data favor the hypoth-
esis that microRNAs are important regulators of genes relevant to
malaria pathogenesis.
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